Your browser doesn't support javascript.
loading
Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies.
Mercader-Ruiz, Jon; Beitia, Maider; Delgado, Diego; Sánchez, Pello; Porras, Begoña; Gimeno, Irene; González, Sergio; Benito-Lopez, Fernando; Basabe-Desmonts, Lourdes; Sánchez, Mikel.
Affiliation
  • Mercader-Ruiz J; Microfluidics Cluster UPV/EHU BIOMICs Microfluidics Group Lascaray Research Center University of the Basque Country UPV/EHU 01006, Vitoria-Gasteiz, Spain.
  • Beitia M; Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Delgado D; Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Sánchez P; Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Porras B; Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Gimeno I; Arthroscopic Surgery Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • González S; Arthroscopic Surgery Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Benito-Lopez F; Advance Biological Therapy Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Basabe-Desmonts L; Arthroscopic Surgery Unit Hospital Vithas Vitoria 01008, Vitoria-Gasteiz, Spain.
  • Sánchez M; Microfluidics Cluster UPV/EHU Analytical Microsystems & Materials for Lab-on-a-Chip (AMMa-LOAC) Group Analytical Chemistry Department University of the Basque Country UPV/EHU 48940, Leioa, Spain.
Biomed Res Int ; 2024: 6444120, 2024.
Article in En | MEDLINE | ID: mdl-39157212
ABSTRACT
Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet-rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP-obtaining methods that attempt to modify the molecular composition of the plasma.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Rich Plasma Limits: Animals / Humans Language: En Journal: Biomed Res Int Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Rich Plasma Limits: Animals / Humans Language: En Journal: Biomed Res Int Year: 2024 Document type: Article Affiliation country: